Takaisin

Effectiveness of Glucocorticoid injection for Greater Trochanteric Pain Syndrome

Näytönastekatsaukset
Eveliina Heikkala and Kalle Saikkonen
3.3.2026

Level of evidence: D

The evidence on glucocorticoid-injection for Greater Trochanteric Pain Syndrome is very uncertain.

A systematic review with meta-analysis «Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 compared glucocorticoid + local anesthetic injection with usual care wait and see strategy or placebo in treatment of GTPS and found uncertain impact on short term (4-6 weeks pain). A small randomized controlled study «Nissen MJ, Brulhart L, Faundez A, et al. Glucocort...»2 compared glucocorticoid + local anesthetic injection with placebo in treatment of GTPS and found little to no impact.

On medium term and long term, the impact remained uncertain.

The quality of the evidence is downgraded due to risk of bias, inconsistency and imprecision.

Table 1. Description of the included studies
Reference Study type Population Intervention and comparison Outcomes Risk of bias
RCT=randomized controlled trial; SR=systematic review; MA=meta-analysis
«Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 SR/MA of RCTs Adult patients with GTPS. Glucocorticoid + local anesthetic injection vs. wait and see and usual care or placebo Short-, medium-, long-term, and extra long-term pain intensity Moderate
«Nissen MJ, Brulhart L, Faundez A, et al. Glucocort...»2 RCT Adult patients with GTPS. Ultrasound-guided glucocorticoid + local anesthetic injection vs. placebo Short-term pain intensity Low
Table 2. Additional comments for included studies
Reference Comments
«Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 Wide inclusion criteria without definition of the outcome measures for the literature search. Patients with ongoing treatments were not excluded even though studies included had excluded those patients. Diagnostic criteria for GTPS were not clearly defined thus varied. Highly limited number of studies involved.
Bias of included studies:
Allocation concealment and blinding of outcome assessment was not described/mentioned in one study.
Blinding was not performed in both.
«Nissen MJ, Brulhart L, Faundez A, et al. Glucocort...»2 Double-blinded study with a successful randomization. All patients participated in the follow-up. No selective outcome reporting or incomplete data. Blinding of outcome assessment was not mentioned. Pain intensity was assessed 30 min after the injection that may have influenced the blinding. Concurrent treatments were requested to be avoided, but usage of pain medication was not screened. Target number of patients was not exceeded.

Results

Table 3. Short-term pain intensity in NRS scale of 0-10 (1 to 6 weeks)
Reference Number of studies and number of patients (I/C) Follow-up time Mean (sd) I Mean (sd) (%) C Std. Mean difference (95% CI)
Level of evidence: very low
The quality of evidence is downgraded due to study limitations, inconsistency, indirectness, imprecision.
I=intervention; C=comparison; CI=confidence interval
«Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 3 studies, 300 patients (147/153) 4-6 weeks NA NA -0.45 (-1.06 to 0.17)
«Nissen MJ, Brulhart L, Faundez A, et al. Glucocort...»2 One, 46 patients (21/25) 4 weeks NA NA Not reported. Reduction of NRS: Intervention group: -1.5
Control group:
-2.5
(p=0.23)
Table 4. Medium-term pain intensity in NRS scale of 0-10 (6 to ≤ 12 weeks)
Reference Number of studies and number of patients (I/C) Follow-up time Mean (sd)) I Mean (sd) C Std. Mean difference (95% CI)
Level of evidence: low
The quality of evidence is downgraded due to study limitations. One small trial using placebo as control did not measure medium or long-term follow ups.
I=intervention; C=comparison; CI=confidence interval
«Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 2 studies, 254 (126/128) 8 weeks to 3 months NA NA -0.47 (-0.72, -0.22)
Table 5. Long-term pain intensity in NRS scale of 0-10 (3-6 months)
Reference Number of studies and number of patients (I/C) Follow-up time Mean (sd) I Mean (sd) C Std. Mean difference (95% CI)
Level of evidence: low
The quality of evidence is downgraded due to study limitations and imprecision. One small trial using placebo as control did not measure medium or long-term follow ups.
I=intervention; C=comparison; CI=confidence interval
«Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 Comparison A: 2 studies, 254 (126/128) 6 months NA NA -0.08 (-0.33, 0.16)
Table 6. Extra long-term pain intensity in NRS scale of 0-10 (≥12 months))
Reference Number of studies and number of patients (I/C) Follow-up time Mean (sd) I Mean (sd) C Std. Mean difference (95% CI)
Level of evidence: low
The quality of evidence is downgraded due to study limitations and imprecision. One small trial using placebo as control did not measure medium or long-term follow ups.
I=intervention; C=comparison; CI=confidence interval
«Wang Y, Wang K, Qin Y, et al. The effect of cortic...»1 Comparison A: 2 studies, 254 (126/128) 12 months NA NA -0.27 (-0.52, -0.02)

References

  1. Wang Y, Wang K, Qin Y, et al. The effect of corticosteroid injection in the treatment of greater trochanter pain syndrome: a systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res 2022;17(1):283 «PMID: 35598025»PubMed
  2. Nissen MJ, Brulhart L, Faundez A, et al. Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial. Clin Rheumatol 2019;38(3):647-655 «PMID: 30267357»PubMed